Hepatobiliary & Pancreatic Diseases International

Scope & Guideline

Fostering collaboration for a healthier future in gastroenterology.

Introduction

Immerse yourself in the scholarly insights of Hepatobiliary & Pancreatic Diseases International with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1499-3872
PublisherELSEVIER
Support Open AccessNo
CountrySingapore
TypeJournal
Convergefrom 2002 to 2024
AbbreviationHEPATOB PANCREAT DIS / Hepatob. Pancreatic. Dis. Int.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hepatobiliary & Pancreatic Diseases International' focuses on advancing knowledge in the fields of hepatology, biliary diseases, and pancreatic disorders. It aims to provide a platform for high-quality research that contributes to clinical practice and improves patient outcomes in these areas.
  1. Liver Diseases and Transplantation:
    The journal emphasizes research on various liver diseases, including hepatocellular carcinoma, liver cirrhosis, and liver transplantation techniques. It aims to improve understanding of disease mechanisms and enhance surgical and therapeutic approaches.
  2. Pancreatic Disorders:
    There is a significant focus on pancreatic diseases, particularly pancreatic cancer and pancreatitis. The journal publishes studies on diagnosis, treatment strategies, and novel surgical techniques related to these conditions.
  3. Biliary Pathology:
    Research on biliary diseases, including cholangiocarcinoma and complications from biliary interventions, is a core area. The journal explores both surgical and non-surgical management options.
  4. Innovative Surgical Techniques:
    The journal highlights advancements in surgical methods, including minimally invasive techniques and robotic surgery, aimed at improving patient outcomes in liver and pancreatic surgeries.
  5. Clinical and Translational Research:
    Emphasizing the bridge between laboratory research and clinical application, the journal encourages studies that translate scientific findings into practical treatments for liver and pancreatic diseases.
  6. Immunotherapy and Molecular Approaches:
    There is a growing interest in the role of immunotherapy and molecular biology in the treatment of hepatobiliary and pancreatic cancers, reflecting modern therapeutic strategies.
The journal has identified several emerging themes that reflect the latest advancements and interests in the fields of hepatology and pancreatic diseases. These trends are indicative of the evolving landscape of research and clinical practice.
  1. Personalized Medicine and Genomics:
    There is an increasing focus on personalized medicine approaches, including genomic profiling and tailored therapies for hepatobiliary and pancreatic cancers, reflecting the trend towards individualized patient care.
  2. Immunotherapy Advances:
    Research on immunotherapy, including checkpoint inhibitors and novel immunotherapeutic strategies, has gained significant traction, highlighting its potential in treating liver and pancreatic cancers.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning for diagnostics and treatment predictions is on the rise, showcasing innovations in data-driven approaches to hepatobiliary and pancreatic diseases.
  4. Multidisciplinary Approaches to Treatment:
    Emerging themes include collaborative, multidisciplinary approaches to managing complex cases in hepatobiliary and pancreatic surgery, integrating surgical, medical, and supportive care.
  5. Microbiome and Liver Health:
    Research exploring the relationship between the gut microbiome and liver disease is gaining attention, indicating a growing interest in the microbiome's role in health and disease.
  6. Regenerative Medicine and Stem Cell Therapy:
    There is an increasing exploration of regenerative medicine and stem cell therapy as potential treatments for liver diseases, reflecting advancements in biological therapies.

Declining or Waning

While the journal continues to explore a broad range of topics, certain areas of research have shown a decline in focus over recent years. This may reflect shifts in clinical priorities or advancements in treatment methodologies that have rendered some topics less relevant.
  1. Traditional Surgical Techniques:
    There appears to be a waning emphasis on traditional open surgical techniques for hepatobiliary and pancreatic surgeries, as the field increasingly adopts minimally invasive and robotic approaches.
  2. Conventional Imaging Techniques:
    With the advent of advanced imaging modalities and radiomics, traditional imaging methods for diagnosing liver and pancreatic diseases are becoming less prominent in the journal's publications.
  3. Single-Agent Chemotherapies:
    Research focused solely on single-agent chemotherapy regimens for hepatobiliary malignancies has decreased, likely due to the shift towards combination therapies and personalized medicine.
  4. Basic Science Studies:
    There is a noticeable decline in basic science studies that do not directly translate to clinical practice, as the journal prioritizes research with immediate clinical applicability.
  5. Epidemiological Studies without Novel Insights:
    Epidemiological studies that do not provide new insights or advancements in understanding disease mechanisms or treatment are becoming less frequent.

Similar Journals

Pancreatology

Connecting Research and Clinical Practice in Pancreatology
Publisher: ELSEVIERISSN: 1424-3903Frequency: 6 issues/year

Pancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.

HPB

Shaping the future of Gastroenterology and Hepatology.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Translational Gastroenterology and Hepatology

Leading the Charge in Translational Medicine for Digestive Health.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Clinical and Molecular Hepatology

Elevating understanding and treatment of liver conditions.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Journal of the Pancreas

Transforming understanding into improved pancreatic care.
Publisher: E S BURIONI RICERCHE BIBLIOGRAFICHEISSN: 1590-8577Frequency: 6 issues/year

Journal of the Pancreas is a pivotal academic publication dedicated to advancing our understanding of pancreatic diseases and disorders. Published by E S Burioni Ricerche Bibliografiche, this journal aims to disseminate novel research findings, case studies, and reviews pertaining to the diagnosis, treatment, and management of pancreatic conditions. With its ISSN 1590-8577, the journal has made significant contributions to the medical field since its inception in 2000, although it ceased its coverage in Scopus in 2015. The Journal of the Pancreas is particularly valuable for researchers, healthcare professionals, and students in gastroenterology and related fields, as it supports evidence-based practices and promotes collaboration in the exploration of pancreatic health. The importance of this journal is underscored by its commitment to providing high-quality, peer-reviewed research that informs clinical approaches and enhances patient outcomes.

International Journal of Hepatology

Exploring the frontiers of liver disease management.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

ZEITSCHRIFT FUR GASTROENTEROLOGIE

Cultivating Academic Excellence in Gastroenterology
Publisher: GEORG THIEME VERLAG KGISSN: 0044-2771Frequency: 12 issues/year

ZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.

International Journal of Hepatobiliary and Pancreatic Diseases

Connecting Researchers and Clinicians for Global Health Solutions
Publisher: EDORIUM JOURNALSISSN: 2230-9012Frequency: 1 issue/year

International Journal of Hepatobiliary and Pancreatic Diseases (ISSN: 2230-9012) is a pivotal publication dedicated to advancing knowledge in the fields of hepatology, biliary tract, and pancreatic diseases. Published by EDORIUM JOURNALS, this esteemed journal aims to provide a platform for cutting-edge research, critical reviews, and clinical studies that address complex issues affecting the liver, biliary system, and pancreas. With a strong commitment to open access, the journal facilitates the dissemination of vital findings to researchers, clinicians, and healthcare professionals worldwide. Recognizing the importance of these disciplines in combating global health challenges, the International Journal of Hepatobiliary and Pancreatic Diseases welcomes submissions that contribute to the understanding of pathophysiology, treatment advancements, and innovative surgical techniques. For researchers eager to impact patient care and medical knowledge, this journal serves as an essential resource in the ongoing dialogue on liver and pancreatic health.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Exploring innovative solutions in gastroenterology.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Hepatology International

Innovating hepatology for a healthier tomorrow.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.